Skip to content
Screener

Globus Medical GMED Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$868K+214%
Boston Scientific logo
Boston ScientificBSX
-$30M-700%
Enovis logo
EnovisENOV
$0-100%
IAR
Integra LifeSciencesIART
——
CONMED logo
CONMEDCNMD
——

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$11.18B+44.1%
Enterprise value$10.78B+41.1%
P/E20.9×-0.9×
P/S3.6×+0.6×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0×0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(In thousands)Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Amortization of acquisition accounting fair value step up—12,673
Stock-based compensation expense26,00026,823
Allowance for expected credit losses10,3984,554
Change in fair value of business acquisition liabilities16,0595,389
Change in deferred income taxes15,748(41,236)
(Gain)/loss on disposal of assets, net5,5586,131
Payment of business acquisition-related liabilities(2,596)(15,764)
Net (gain)/loss from foreign currency adjustment218(11,342)

Item 1. Financial Statements

FAQ

What is Globus Medical's contingent consideration fair value adjustments?
Globus Medical (GMED) reported contingent consideration fair value adjustments of $9.71M in Q2 2026.
How has Globus Medical's contingent consideration fair value adjustments changed year-over-year?
Globus Medical's contingent consideration fair value adjustments increased by 85.9% year-over-year, from $5.22M to $9.71M.
What is the long-term trend for Globus Medical's contingent consideration fair value adjustments?
Over 2 years (2021 to 2023), Globus Medical's contingent consideration fair value adjustments has grown at a 1.8% compound annual growth rate (CAGR), from $16.81M to $17.43M.
What does contingent consideration fair value adjustments mean?
Contingent consideration fair value adjustments

Ask your AI about Globus Medical's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude